J. Biol. Chem., Vol. 266, Issue 9, 5388-5394, 03, 1991
Evaluation of cysteine 283 and glutamic acid 284 in the coenzyme binding site of Salmonella typhimurium glutamate dehydrogenase by site- directed mutagenesis and reaction with the nucleotide analogue 2-[4- bromo-2,3-dioxobutyl)thio)-1,N6-ethenoadenosine 2',5'-bisphosphate
L Haeffner-Gormley, ZD Chen, H Zalkin and RF Colman
Department of Chemistry and Biochemistry, University of Delaware, Newark 19716.
NADP(+)-specific glutamate dehydrogenase of Salmonella typhimurium was
previously shown to react irreversibly at the coenzyme site with the
nucleotide analogue 2-((4-bromo-2,3-dioxobutyl)thio)-1,N6- ethenoadenosine
2',5'-bisphosphate (2-BDB-T epsilon A 2',5'-DP) yielding a partially active
enzyme, and inactivation was attributed to modification of the peptide
Leu282-Cys-Glu-Ile-Lys286 (Bansal, A., Dayton, M.A., Zalkin, H., and
Colman, R.F. (1989) J. Biol. Chem. 264, 9827-9835). Three mutant enzymes
have now been engineered, expressed in Escherichia coli, and purified: the
single mutants C283I and E284Q and the double mutant C283I:E284Q. The
wild-type and mutant enzymes have similar specific activities and Km values
for alpha-ketoglutarate, ammonium ion, and NADPH, indicating that neither
cysteine 283 nor glutamic acid 284 is essential for activity. The mutant
enzyme E284Q, like wild-type glutamate dehydrogenase, is substantially
inactivated by 2-BDB-T epsilon A 2',5'-DP. In contrast, the two cysteine
mutant enzymes, C283I and C283I:E284Q, are not inactivated by 2-BDB-T
epsilon A 2',5'-DP. Modified tryptic peptides with the sequence
Leu-X-Glu(Gln)- Ile-Lys were isolated from wild-type or E284Q enzymes
inactivated by 2- BDB-T epsilon A 2',5'-DP. This peptide was absent from
digests of active wild-type enzyme modified in the presence of the
protectant NADPH and from digests of active C283I enzyme after incubation
with 2- BDB-T epsilon A 2',5'-DP. Although it is not required for catalytic
activity, cysteine 283 is implicated by the results of the affinity
labeling experiments as the reaction target of the nucleotide analogue and
is located in the region of the coenzyme binding site.